Department of Neuroscience,WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation,Biomedicine and Movement Sciences,Section of Psychiatry,University of Verona,Verona,Italy.
Strathclyde Institute of Pharmacy and Biomedical Sciences,Strathclyde University,Glasgow,UK.
Epidemiol Psychiatr Sci. 2018 Feb;27(1):24-28. doi: 10.1017/S2045796017000464.
Research evidence guiding the identification of pragmatic and effective actions aimed at improving the selection, availability, affordability and rational prescribing of medicines for mental disorders is sparse and inconsistent. In order to boost the development of new research, in this commentary we suggest to organise and classify all the activities in this area under a common theoretical framework and nomenclature, adopting the term 'public health psychopharmacology'. Public health psychopharmacology is proposed as a research discipline, based on contributions from the fields of regulatory science, health services research and implementation science. Implementing the term public health psychopharmacology may offer advantages, as the scientific community would be more focused on common goals and objectives, with, likely, an increasing body of research evidence of practical use.
指导识别旨在改善精神障碍药物选择、可及性、可负担性和合理处方的实用有效措施的研究证据稀缺且不一致。为了促进新研究的发展，在这篇评论中，我们建议在一个通用的理论框架和命名法下组织和分类该领域的所有活动，采用“公共卫生精神药理学”一词。公共卫生精神药理学是基于监管科学、卫生服务研究和实施科学领域的贡献而提出的一个研究学科。实施“公共卫生精神药理学”一词可能具有优势，因为科学界将更加关注共同的目标，并且可能会有越来越多实用的研究证据。
